WOE of Anti-CD20 Therapies

Clinical trial NCT06121349 · COMPLETED

Trial details

NCT number: NCT06121349
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2023-12-04
Primary completion: 2025-06-13
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.